Skip to main content
FinSpry Logo
FinSpry
SLNO logo
SLNO
(NASDAQ)
Soleno Therapeutics, Inc.
$53.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Soleno Therapeutics (SLNO) Stock Price & Financial Analysis

Soleno Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$53.01 - $53.01
52-Week High$90.32
52-Week Low$29.43
Open$53.01
Average Volume (3M)3.35M
Market Cap2.88B
Shares Outstanding54.33M
P/E Ratio (TTM)137.87
Price to Sales (P/S)15.13
Price to Book (P/B)6.40
EV/EBITDA121.82
Revenue (TTM)190.41M
Net Income (TTM)20.89M
Free Cash Flow (TTM)46.73M
EPS (TTM)$0.41
Profit Margin10.97%
Operating Margin7.53%
Return on Equity (ROE)4.64%
Debt to Equity0.01
50-Day MA$45.79
200-Day MA$52.40
52-Week Change-29.33%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Soleno Therapeutics

What is the current stock price for SLNO?

As of the latest trading session, SLNO stock trades at $53.01. The 52-week range is $29.43–$90.32, with a day range of $53.01–$53.01.

What is the P/E ratio for SLNO?

Soleno Therapeutics's trailing P/E ratio is 137.9, meaning investors pay $137.9 for every $1 of annual earnings.

Does SLNO pay dividends?

Soleno Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SLNO?

Based on 6 analysts, the consensus for SLNO is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SLNO?

Soleno Therapeutics's market capitalization is $2.88B, classifying it as a mid-cap company..